A Glimpse Into The Expert Outlook On NICE Through 12 Analysts

Over the last three months, twelve analysts have evaluated NICE (NASDAQ:NICE), with a mix of bullish and indifferent ratings, resulting in an average 12-month price target of $199.25, a slight decrease from the previous average of $201.92. Recent analyst actions include Piper Sandler and DA Davidson raising their price targets while Citigroup and Morgan Stanley lowered theirs, reflecting adjustments to NICE's valuation based on market conditions and company performance; NICE's revenue growth lags behind industry peers, but it boasts a standout net margin of 18.46% and strong ROE and ROA.

Analysis

Over the past three months, twelve analysts have evaluated NICE (NASDAQ:NICE), resulting in a predominantly positive outlook with five bullish, five somewhat bullish, and two indifferent ratings; notably, rating activity in the most recent 30-day period was limited to a single 'Indifferent' stance. The average 12-month price target for NICE has experienced a slight moderation, decreasing by 1.32% to $199.25 from the previous average of $201.92, with individual analyst targets exhibiting significant dispersion, ranging from a low of $161.00 to a high of $300.00. Recent specific analyst actions reflect a mixed sentiment: Piper Sandler raised its Neutral target to $182.00 (from $153.00) and DA Davidson increased its Buy target to $185.00 (from $180.00), while Citigroup lowered its Buy target to $211.00 (from $214.00) and Morgan Stanley reduced its Overweight target to $202.00 (from $235.00). Financially, NICE reported revenue growth of approximately 6.2% as of March 31, 2025; while this indicates expansion, it trails the growth rates of its peers in the Information Technology sector. Conversely, the company demonstrates exceptional profitability, evidenced by an impressive net margin of 18.46%, which significantly exceeds industry averages. This financial strength is further underscored by a return on equity (ROE) of 3.65% and a return on assets (ROA) of 2.46%, both surpassing industry benchmarks, alongside a prudent financial strategy reflected in a low debt-to-equity ratio of 0.15. The company's market capitalization is noted as being smaller compared to industry averages.

Key Decisions for Investors

• Investors should carefully weigh NICE's strong profitability metrics, particularly its high net margin of 18.46% and solid ROE and ROA, against its revenue growth of 6.2% which currently lags industry peers.
• The recent 1.32% decrease in the average analyst price target to $199.25, combined with mixed individual analyst revisions and a wide target range ($161.00-$300.00), suggests diligent monitoring of future earnings reports and evolving market conditions.